Latest News about ALKS

Recent news which mentions ALKS

< Previous 1 2 3 4 5 Next >

Alkermes Earnings Conference Call Is Coming Up, Here's What You Need To Know

April 22, 2022

Expert Ratings for Alkermes

April 21, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022

April 20, 2022

Alkermes Starts Arbitration Related to NanoCrystal Tech Agreements With Janssen

April 19, 2022

This Biotech Company Is Landing Ketamine-Assisted Therapy In England's Capital

March 31, 2022

This Ketamine-Assisted Therapy Company Is Developing New Ways To Treat Alcohol Addiction

March 24, 2022

The Daily Biotech Pulse: Moderna Files For 2nd COVID Booster Shot Authorization, Lexicon Secures Debt Funding, Amneal Gets Sub-License to Manufacture Generic COVID Pill

March 18, 2022

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings

March 13, 2022

Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer

February 17, 2022

Alkermes's Return On Capital Employed Overview

February 17, 2022

56 Biggest Movers From Yesterday

February 17, 2022

Why Alkermes Stock Blasted 15% Higher Today

February 16, 2022

Alkermes (ALKS) Q4 2021 Earnings Call Transcript

February 16, 2022

Why Are Alkermes Shares Trading Higher Today?

February 16, 2022

40 Stocks Moving In Wednesday's Mid-Day Session

February 16, 2022

The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa

February 16, 2022

Recap: Alkermes Q4 Earnings

February 16, 2022

Earnings Scheduled For February 16, 2022

February 16, 2022

Earnings Preview For Alkermes

February 15, 2022

The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More

February 13, 2022

Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia

February 08, 2022

The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar

February 08, 2022

Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022

January 27, 2022

BioCorRx Aims To Help Combat Opioid Crisis With Implantable Naltrexone Drug Candidate BICX104

January 24, 2022

The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug

January 20, 2022

Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021

December 01, 2021

Direxion Launches New Nanotechnology ETF, TYNE

November 23, 2021

75 Biggest Movers From Yesterday

November 10, 2021

Janssen Partially Terminates Nanoparticle License Agreement With Alkermes

November 09, 2021

Why Alkermes Stock Is Sinking Today

November 09, 2021

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.